SB-201

SB-201 is an investigational hepatocyte-based tissue therapeutic being developed by Satellite Bio for the treatment of advanced liver diseases, including decompensated cirrhosis and hepatic encephalopathy. The therapy is built upon the company's proprietary Satellite Tissue platform, which involves engineering functional liver tissue (Satellite Tissues) that can be implanted into the body. SB-201 is designed to act as a cell replacement or supplementation therapy, providing healthy, functional hepatocytes to restore essential metabolic, synthetic, and detoxification functions of the liver. By boosting overall liver function, SB-201 aims to improve clinical outcomes and reduce mortality in patients with chronic liver disease who have limited therapeutic options.